-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Medpace Hldgs, Raises Price Target to $525

Benzinga·12/15/2025 21:03:10
語音播報
Barclays analyst Luke Sergott maintains Medpace Hldgs (NASDAQ:MEDP) with a Underweight and raises the price target from $485 to $525.